HOUSTON, TEXAS / ACCESS Newswire / January 28, 2025 / The Mayan Languages Preservation and Digitization Project, supported by ...

CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad hoc announcement pursuant to Art. 53 LR In 2024, Lonza ...

According to Business Research Insights the Portable Home Ventilator Market expected to exhibit a CAGR of 10.5% by 2033.The ...

Leading UK contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions, has completed the build of ...

Isomerase has formed a strategic partnership with BugBiome, which is focused on the discovery of novel targeted ...

Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, ...

Thermo Fisher Scientific, the world leader in serving science, today announced the introduction of Olink® Reveal, setting a ...

This is Dermata's first issued U.S. patent for XYNGARI™, which uses its Spongilla technology to topically treat acne -- Dermata expects to announce topline results from its STAR-1 Phase 3 XYNGARI™ ...

SACRAMENTO, CALIFORNIA / ACCESS Newswire / January 28, 2025 / Paragon Health IT announced a strategic reorganization effective January 1, 2025. As part of this reorganization, Paragon Health IT will ...

AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has been approved in the US for the treatment of adult patients with unresectable or metastatic hormone receptor (HR)-positive, ...

AcceleDev Chemical LLC, a leading contract development and manufacturing organization (CDMO) specializing in custom synthesis and process development, is pleased to announce the appointment of Dr.

A range of clinical topics will be covered throughout the year at the in-person events held in Southern California. NEWPORT BEACH, CALIFORNIA / ACCESS Newswire / January 28, 2025 / Glidewell has ...